| 2024-01 |
Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes |
Frontiers in Endocrinology
|
| 2024-01 |
Association of Muscle Mass Loss with Diabetes Development in Liver Transplantation Recipients |
Diabetes and Metabolism Journal
|
| 2023-09 |
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study |
Journal of Gastroenterology and Hepatology
|
| 2023-09 |
Clinical Effects of a Home Care Pilot Program for Patients with Type 1 Diabetes Mellitus: A Retrospective Cohort Study |
Diabetes and Metabolism Journal
|
| 2023-07 |
β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months: Type 2 diabetes and β-hydroxybutyrate level |
Diabetes and Metabolism
|
| 2023-05 |
Machine-learning enhancement of urine dipstick tests for chronic kidney disease detection |
Journal of the American Medical Informatics Association : JAMIA
|
| 2023-02 |
Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes |
FRONTIERS IN ENDOCRINOLOGY
|
| 2023-01 |
Prognostic value of resting heart rate in predicting undiagnosed diabetes in adults: Korean National Health and Nutrition Examination Survey 2008–2018 |
Nutrition, Metabolism and Cardiovascular Diseases
|
| 2022-09 |
Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study |
Diabetes and Metabolism Journal
|
| 2022-08 |
Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model |
ENDOCRINOLOGY AND METABOLISM
|
| 2022-08 |
The effects of the voglibose on non-alcoholic fatty liver disease in mice model |
SCIENTIFIC REPORTS
|
| 2022-06 |
Tolerability and Effectiveness of Switching to Dulaglutide in Patients with Type 2 Diabetes Inadequately Controlled with Insulin Therapy |
Frontiers in Endocrinology
|
| 2022-06 |
Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes |
YONSEI MEDICAL JOURNAL
|
| 2022-04 |
Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21 |
FRONTIERS IN IMMUNOLOGY
|
| 2022-04 |
Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort Study |
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
|
| 2022-03 |
Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease |
Gut and Liver
|
| 2022-03 |
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease |
GUT AND LIVER
|
| 2022-03 |
DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice |
Diabetes and Metabolism Journal
|
| 2022-03 |
Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study) |
BMC MEDICINE
|
| 2022-02 |
Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease |
Jama Network Open
|
| 2022-01 |
Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus |
Diabetes and Metabolism Journal
|
| 2022-01 |
Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People |
HYPERTENSION
|
| 2021-12 |
Targeting PLD2 in adipocytes augments adaptive thermogenesis by improving mitochondrial quality and quantity in mice |
JOURNAL OF EXPERIMENTAL MEDICINE
|
| 2021-12 |
Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes |
Frontiers in Cardiovascular Medicine
|
| 2021-11 |
Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetes |
DIABETES RESEARCH AND CLINICAL PRACTICE
|
| 2021-11 |
Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway |
Diabetes and Metabolism Journal
|
| 2021-08 |
Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts |
Endocrinology and Metabolism
|
| 2021-06 |
Association between domain-specific physical activity and diabetes in Korean adults |
SCIENTIFIC REPORTS
|
| 2021-05 |
Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance study |
DIABETES OBESITY & METABOLISM
|
| 2021-04 |
Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes |
DIABETES OBESITY & METABOLISM
|
| 2020-12 |
Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name |
METABOLISM-CLINICAL AND EXPERIMENTAL
|
| 2020-11 |
Effect of Ezetimibe on Glucose Metabolism and Inflammatory Markers in Adipose Tissue |
Biomedicines
|
| 2020-11 |
Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
|
| 2020-10 |
Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis |
METABOLISM-CLINICAL AND EXPERIMENTAL
|
| 2020-10 |
Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression |
SCIENTIFIC REPORTS
|
| 2020-08 |
Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes |
MEDICINE
|
| 2020-06 |
Nonalcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes a Korean cohort study |
CARDIOVASCULAR DIABETOLOGY
|
| 2020-05 |
SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease |
NATURE COMMUNICATIONS
|
| 2020-05 |
Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo |
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS
|
| 2020-04 |
Gamma glutamyltransferase and risk of dementia in prediabetes and diabetes |
SCIENTIFIC REPORTS
|
| 2020-04 |
Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus |
Diabetes and Metabolism Journal
|
| 2020-04 |
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk |
AMERICAN JOURNAL OF GASTROENTEROLOGY
|
| 2020-04 |
Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naïve people with type 2 diabetes: The EDITION AP randomized controlled trial |
DIABETES OBESITY & METABOLISM
|
| 2020-03 |
Comparison of Renal Effects of Ezetimibe-Statin Combination versus Statin Monotherapy: A Propensity-Score-Matched Analysis |
Journal of Clinical Medicine
|
| 2020-03 |
Effect of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on gluconeogenesis in proximal renal tubules |
DIABETES OBESITY & METABOLISM
|
| 2020-01 |
Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 DiabetesControlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial |
Journal of Clinical Medicine
|
| 2020-01 |
Efficacy and safety of gemigliptin as add-on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study) |
DIABETES OBESITY & METABOLISM
|
| 2020-01 |
Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes |
Journal of Lipid and Atherosclerosis
|
| 2020-01 |
Proteinuria is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study |
Journal of Clinical Medicine
|
| 2020-01 |
Cohort Profile: Firefighter Research on the Enhancement of Safety and Health (FRESH), a Prospective Cohort Study on Korean Firefighters |
YONSEI MEDICAL JOURNAL
|
| 2019-12 |
Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus |
TRANSPLANTATION PROCEEDINGS
|
| 2019-11 |
Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors |
DIABETES CARE
|
| 2019-10 |
The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis |
Journal of Clinical Medicine
|
| 2019-09 |
Injectable Therapy for Diabetes Mellitus: Glucagon-Like Peptide-1 Receptor Agonist |
The Journal of Korean Diabetes
|
| 2019-09 |
Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea |
Endocrinology and Metabolism
|
| 2019-08 |
Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuria |
JOURNAL OF DIABETES AND ITS COMPLICATIONS
|
| 2019-08 |
Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
| 2019-07 |
Risk of Incident Dementia According to Metabolic Health and Obesity Status in Late Life: A Population-Based Cohort Study |
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
|
| 2019-06 |
Incident Hepatocellular Carcinoma Risk in Patients Treated with a Sulfonylurea: A Nationwide, Nested, Case-Control Study |
SCIENTIFIC REPORTS
|
| 2019-05 |
Spontaneous ketonuria and risk of incident diabetes: a 12 year prospective study |
DIABETOLOGIA
|
| 2019-05 |
Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms |
SEMINARS IN LIVER DISEASE
|
| 2019-04 |
Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors |
Diabetes and Metabolism Journal
|
| 2019-04 |
Sodium-glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter-organ crosstalk |
DIABETES OBESITY & METABOLISM
|
| 2019-03 |
Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus. |
SCIENTIFIC REPORTS
|
| 2019-03 |
Reduced expression of pyruvate kinase in kidney proximal tubule cells is a potential mechanism of pravastatin altered glucose metabolism |
SCIENTIFIC REPORTS
|
| 2019-03 |
Teneligliptin versus sitagliptin in Korean patients with type2 diabetes inadequately controlled with metformin andglimepiride: A randomized, double-blind, non-inferiority trial |
DIABETES OBESITY & METABOLISM
|
| 2019-02 |
Differential effects of thiazolidinediones and dipeptidyl peptidase-4 inhibitors on insulin resistance and b-cell function in type 2 diabetes mellitus: A propensity score-matched analysis |
DIABETES THERAPY
|
| 2019-02 |
Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients |
SCIENTIFIC REPORTS
|
| 2019-01 |
Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide |
DIABETES & METABOLISM
|
| 2018-11 |
Relationship Between Circulating Netrin-1 Concentration, Impaired Fasting Glucose, and Newly Diagnosed Type 2 Diabetes |
Frontiers in Endocrinology
|
| 2018-11 |
Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes |
DIABETES & METABOLISM
|
| 2018-08 |
Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B |
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
|
| 2018-08 |
Elevated N-acetyl-beta-D-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study |
JOURNAL OF DIABETES AND ITS COMPLICATIONS
|
| 2018-08 |
Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study |
SCIENTIFIC REPORTS
|
| 2018-07 |
Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus |
Frontiers in Endocrinology
|
| 2018-06 |
Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitor and Its Possible Cardioprotective Mechanism |
한국지질동맥경화학회지
|
| 2018-06 |
Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis |
대한내분비학회지
|
| 2018-05 |
Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2018-04 |
The association between skin auto-fluorescence of palmoplantar sites and microvascular complications in Asian patients with type 2 diabetes mellitus |
SCIENTIFIC REPORTS
|
| 2018-04 |
Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients |
JOURNAL OF HEPATOLOGY
|
| 2018-03 |
Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db mice |
INTERNATIONAL JOURNAL OF OBESITY
|
| 2018-03 |
Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer |
대한내분비학회지
|
| 2018-03 |
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study |
JOURNAL OF HEPATOLOGY
|
| 2017-11 |
Impact of diabetes mellitus and chronic liver disease on the incidence of dementia and all-cause mortality among patients with dementia |
MEDICINE
|
| 2017-10 |
Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated mediated activation of autophagy and NLRP3 inflammasome inhibition |
AUTOPHAGY
|
| 2017-06 |
Pre-sarcopenia is associated with renal hyperfiltration independent of obesity or insulin resistance: Nationwide Surveys (KNHANES 2008-2011) |
MEDICINE
|
| 2017-06 |
Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes |
대한내분비학회지
|
| 2017-06 |
Diabetes self-assessment score and the development of diabetes A 10-year prospective study |
MEDICINE
|
| 2017-06 |
The Relationship between Increases in Morning Spot Urinary Glucose Excretion and Decreases in HbA1C in Patients with Type 2 Diabetes After Taking an SGLT2 Inhibitor: A Retrospective, Longitudinal Study7 |
DIABETES THERAPY
|
| 2017-04 |
Anatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008?2011) |
CARDIOVASCULAR DIABETOLOGY
|
| 2017-04 |
High-dose sulphonylurea treatment in patients with renal impairment should be considered with caution |
Evidence-Based Medicine
|
| 2017-04 |
Clinical parameters affecting dapagliflozin response in patients with type 2 dabetes |
DIABETES & METABOLISM
|
| 2017-03 |
Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes |
YONSEI MEDICAL JOURNAL
|